Infinity Executive Management

Jeff Thompson, Interim CEO

read more

Jeffery S. Thompson is a Partner with Tampa, Florida based HealthEdge Investment Partners, LLC, an operating-oriented private equity firm founded in 2005 that provides strategic capital exclusively in the healthcare industry.

Mr. Thompson currently serves as President, CEO, and Chairman of Enaltus, a Suwanee, Georgia based HealthEdge portfolio company specializing in unique skincare solution with direct operations in the US and global distribution partnerships.

Mr. Thompson serves as an Independent Director and Compensation Committee Member with the Board of Directors for Anika Therapeutics, Inc., a publicly traded Bedford, Massachusetts based biotechnology company that develops, manufactures and commercializes therapeutic hylauronic acid based products for tissue protection, healing, repair and regeneration. Mr. Thompson serves as a Director for Inifinity HomeCare, a privately held Florida based home health care provider that focuses on providing patients the highest level of Medicare covered services and therapy available through quality personnel, educational training, and specialty home health care programs.

Mr. Thompson serves as a Director for Advanced Bio-Technologies, Inc. (ABT) a wholly owned subsiduary of Sinclair Pharma, PLC, a publicly traded UK based skincare company, which purchased ABT from HealthEdge and other shareholders while Mr. Thompson served as President, CEO and Chairman. Prior to the strategic sale, ABT focused on the treatment and management of scars with unique patent protected silicone products based on cross-linking technologies marketed under the brands Kelo-cote® and bioCorneum+® through direct operations in the United States and in over 50 countries throughout the world via a network of local marketing partners. Mr. Thompson served as Chairman of Woodbury Products, Inc., an Oceanside, New York based HealthEdge portfolio company dedicated the distribution of high quality incontinence and related healthcare products which was sold to MTS Health Investors in March 2012.

Prior to joining HealthEdge, Mr. Thompson was a Director and the Chief Operating Officer for Stiefel Laboratories, Inc., the world’s largest independent pharmaceutical company specializing in dermatology. Mr. Thompson continued to serve as a member of Stiefel’s Board of Directors through the closing of Glaxo SmithKline’s acquisition of Stiefel in July of 2009. Prior to becoming Stiefel’s COO, Mr. Thompson served as Stiefel’s Senior Vice President U.S. Business Services and President of Glades Pharmaceuticals. During his tenure in this dual leadership role, Glades grew from $36 million to over $73 million.

Earlier in his career, Mr. Thompson held Sales and Business Management positions at Bausch & Lomb Pharmaceuticals and he began his career at SmithKline Beecham as a Professional Sales Representative.

Mr. Thompson received his Bachelor’s degree in General Science after completing one year of study in Dental Medicine, both at the University of Pittsburgh.

Steve Karasick , COO / President

read more

Mr. Karasick joined HealthEdge Investment Partners in 2012 as an Operating Partner focused on Human Capital and Technology. Mr. Karasick currently serves as President and COO of Infinity Homecare, a Florida-based provider of Medicare home health and therapy services.

Prior to working with HealthEdge, Mr. Karasick served as Executive Vice President of Integration and Chief Human Resources Officer (CHRO) at Piedmont Healthcare, a top southeast regional healthcare system. At Piedmont he led the system-wide strategy for integration of a $1.6 billion company with 11,000 employees, 5 hospitals and over 100 locations and reported directly to the CEO. Mr. Karasick was also previously the Senior Vice President of People and Technology at Stiefel Laboratories, Inc., a global pharmaceutical Company founded in 1847 that manufactures and markets a variety of prescription and non-prescription dermatological products. Mr. Karasick was directly involved in the sale of Stiefel to Glaxo SmithKline for $3.6 billion in 2009.

Prior to Stiefel, Mr. Karasick was a partner with Clarkston Consulting, an international firm specializing in enterprise wide technology and change implementation. He has also held business unit leadership positions with Solution 6 Pty. Ltd, a global technology company, and was responsible to lead worldwide client delivery. Mr. Karasick began his career with Andersen Consulting, and consulted in a wide range of sales, finance, audit, customer service, technology, supply chain and manufacturing roles.

Steve is a member of the Board for the Georgia Leukemia & Lymphoma Society, in 2011 served as Chair for the Dream Society of Children's Healthcare of Atlanta (CHOA) and is a member of the CHOA Annual Fund Board. Mr. Karasick earned an M.B.A. from Goizueta Business School at Emory University and is a University of North Carolina at Chapel Hill Morehead Scholar earning a dual B.A. in Physics and Geography.

Ralph Nelson, CFO

read more

Mr. Nelson has been a certified public accountant for the last 26 years and worked in the accounting profession for over 32 years. In his most recent five years, he has been working as a financial consultant for Fund I, and at various times served as part time Chief Financial Officer for five of its six portfolio companies. Prior to working with HealthEdge, Mr. Nelson served for nine years as a Vice President and Controller of Priority Healthcare Corporation, a publicly held national specialty pharmacy and distributor with over $2 billion in annual sales. Priority Healthcare was acquired by Express Scripts, Inc. in 2005. Mr. Nelson's public accounting experience consisted of serving with Deloitte & Touche for four years, most recently at the Manager level. He also has other senior level management experience with several start up entities. Mr. Nelson graduated Summa Cum Laude in 1978 from Saint Leo University with a B.A. in accounting and business management, where he was a NCAA Division II Academic All American basketball player.

Thomas Engala, Senior Vice President of Sales & Marketing

read more

Thomas Engala is the Senior Vice President of Sales for Infinity Homecare, LLC, a representative investment of HealthEdge Investment Partners, and has headed Infinity’s sales force since August, 2011. Infinity Homecare is based in Sarasota, Florida with 13 locations in the state and a hospice located in Aiken, SC. All of its agencies are Medicare-certified, and the team at Infinity is dedicated to delivering high quality services to those in need of homecare. Mr. Engala has 22 years of experience in the healthcare industry. Prior to joining Infinity, he was the Vice-President of Sales of Addus Healthcare, Inc., an equity owned company that went public in 2009. At Addus he was responsible for the development and mentoring of sales performance for their branches in 19 states. At Addus, he grew Medicare Starts of over 20%, developed a sales training manual and training course for new hires, and cut in half the turnover of sales representative in just a 12-month period. He was an Area Vice-President of Sales at TLC Healthcare through its transition to an Amedisys company. His chief goal was to turn around the Southeast region of the company, which, prior to his coming on board, had a spotty performance record. By developing a set of management and sales skills for the Account Executives, Home Health Coordinators, and General Managers, he motivated the team to meet and exceed sales growth objectives. [Mr. Engala has also acted as a consultant for business development for a privately held rehabilitation company, developing new product lines and opportunities for the company. He has co-owned and operationally managed mobile physician practices and has been sales manager for Lifeline Home Health’s Florida region and for Medical Services of America’s Tampa Bay Market.] Mr. Engala has been successful in growing a company’s business, but he knows that it takes a topnotch team to make a company successful. He has been noted for training and mentoring his sales force to become the best they can be, so that the company can be successful. Mr. Engala holds a bachelor’s degree in Business Management from the University of Phoenix.

John J. Piazza Jr., Senior Vice President of Business Development

read more

Mr. John Piazza, Jr. is a 30 year nationally recognized health care veteran who is a visionary leader, creator and builder of health care companies and ancillary businesses. Mr. Piazza’s healthcare experience and career began in a family owned & operated assisted living business named The Adult Care Group. Mr. Piazza, as a minority owner, board member and Senior Executive of Business Development Officer, assisted The Adult Care Group in becoming the nation’s third largest assisted living company in the mid 1990’s which subsequently sold to Summerville/Emeritus Senior Living communities . Leveraging healthcare relationships and the continuum of care created throughout the state of Florida, Mr. Piazza developed multiple health care companies including a Medicare home care company named Senior Home Care. As an owner, operator and Chief Executive Officer of Senior Home Care, Mr. Piazza started Senior Home Care in 1992 and grew it under his leadership to over $50,000,000 in value which was then later sold by Mr Piazza to Summit Partners private equity firm. After buying, building and selling multiple homecare and ancillary health care companies prior to and after the sale of Senior Home Care, Mr. Piazza now uses his broad and vast health care experience and relationships he’s developed over the years to capitalize on strategic business and value creating opportunities for Infinity Home Care as its Sr Vice President of Business Development. Mr. Piazza received his Bachelor of Science in Business Administration after attending University of Missouri/Columbia College, Columbia, Missouri.

Infinity Board of Directors

R. Robert Moxley, Chairman

read more

Robert Moxley is a co-founder and Chairman of the Board for Infinity HomeCare. He brings over thirty years of experience in the health care industry to Infinity. Among the many sales positions he has held throughout the course of his career, he spent over fifteen years as a marketing manager and trainer for Lincare, the most profitable publicly traded home respiratory company in the country. Along with his sales and management experience, Bob has been an integral part in the start up, development, and eventual sale of multiple health care companies. In 1996 he started a private home health company, building to over 135 referrals a month in the Sarasota, FL area. With his sharp business sense and expertise he was able to sell the company to a national health care organization in only three years time. His recent history includes a start-up physician supply and equipment company, which yielded a 70% return profit for its investors in just two years. The combination of his leadership, reputation, and market experience in the health care industry continue to be an invaluable asset to Infinity.

Todd Josephson, Vice Chairman

read more

Mr. Josephson has served as the President/CEO, Board Member of Infinity Home Care since its inception in 2006. Mr. Josephson authored the first business plan for Infinity and co-founded the organization based on his passionate beliefs that patients recover faster and more comfortably at home. The future need for homecare services would increase significantly, the economic advantages and solutions that homecare provides, and the increasing aging population. Mr. Josephson’s strategic vision for the company focuses on several fundamental aspects, including providing outstanding care and support to patients as if they were his own family, attracting and retaining the best clinicians and support staff in the industry, and growing the organization in a compliant and fiscally responsible manner. Mr. Josephson has been engaged in the home health care industry for over 25 years in both the privately held and publically traded sectors. His track record of success prior to Infinity includes the oversight and profitable growth of 22 home health care branch facilities in Florida, South Carolina and North Carolina with HCR Manorcare. Mr. Josephson is a graduate of Mercy College and holds a Bachelors Degree in Marketing and Business Administration.

Brian W. Anderson, Board Member

read more

Mr. Anderson is a Managing Partner and a Founding Principal of HealthEdge Investment Partners. Mr. Anderson shares management responsibility for HealthEdge with Mr. Dingle, and is also responsible for deal generation and overseeing due diligence, transaction structuring, and negotiation, along with fundraising and investor relations. Mr. Anderson is an experienced investor, having over 20 years of experience in private equity, investment banking and finance including with firms such as Robert W. Baird & Co. ("Baird"), Baird Capital Partners ("BCP"), First Chicago Equity Capital and First Chicago Venture Capital. Prior to the formation of Fund I, Mr. Anderson spent the previous six years as a Partner and Managing Director of BCP, Baird's late-stage growth and buyout investment group. While at BCP, Mr. Anderson managed and led investments and oversaw portfolio companies in the healthcare and industrial technology sectors, including four of BCP Fund III's eight lead equity investments. Mr. Anderson has been involved in over 60 private equity investments, add-on acquisitions, advisory, or financing assignments, collectively representing more than $1.8 billion in transaction value. Mr. Anderson received his M.B.A. from the University of Chicago Graduate School of Business with concentrations in Finance, Accounting and Marketing, as well as a B.S. in Finance, Operations and Strategic Management and Philosophy, summa cum laude, from the Carroll School of Management Honors Program of Boston College. Mr. Anderson currently serves on the Board of Directors of Enaltus, Intra-Op Monitoring Services, and Infinity Home Care. Mr. Anderson previously served on the Board of Fund I companies Dispensing Solutions, Advanced Bio-Technologies, Woodbury Health Products, and POC Network Technologies prior to their exit. Mr. Anderson also currently serves on the board of the Tampa Bay Research Institute, the oldest biomedical research organization in Florida.

PhiLlip S. Dingle, Board Member

read more

Mr. Dingle is a Managing Partner and a Founding Principal of HealthEdge Investment Partners. Mr. Dingle shares management responsibility for HealthEdge with Mr. Anderson, and is also responsible for deal generation and overseeing due diligence, transaction structuring, and negotiation, along with fundraising and investor relations. Prior to co-founding the firm, Mr. Dingle served as Chief Executive Officer of publicly-traded PlanVista Corporation (formerly HealthPlan Services Corporation) from 2000 until its merger with ProxyMed, Inc. in 2004, and served as Chairman beginning in 2001. During a four-year period, he and his management team transformed a low-margin, debt-laden third party administrator business into a leaner, and more robust medical cost management firm that became known as PlanVista Solutions. Among his accomplishments as CEO, he divested all of the underperforming operations, enhanced and grew the newly established medical cost management operations by approximately 30%, despite significant balance sheet challenges, drove overall profit margins from under 7% to more than 30% by altering the company's business model, streamlining expenses and leveraging technology, restructured the company's balance sheet, and replaced most of the company's bank debt with financing from a private investment firm, and negotiated the sale of the company to a strategic buyer for $113 million, or more than 10 times trailing 12 months EBITDA. During his tenure at PlanVista, which commenced in 1996, Mr. Dingle also served in the capacities of President and Chief Operating Officer, Chief Financial Officer and Chief Counsel. Prior to his association with PlanVista, Mr. Dingle was a partner in the law firm of Hill, Ward & Henderson, P.A., a Tampa-based law firm. Mr. Dingle holds an LL.M in Taxation from New York University, a J.D. with honors from the University of Florida, and a B.B.A. in Accounting with honors from the University of Notre Dame. Mr. Dingle currently serves on the Board of Directors of Enaltus, Omega Healthcare, and Infinity Home Care. Mr. Dingle previously served on the Board of Fund I companies Dispensing Solutions, Advanced Bio-Technologies, and POC Network Technologies. Mr. Dingle also previously served on the Board of Directors of Alico, Inc. (NASDAQ: ALCO) and currently serves on the Board of Directors of Florida Health Sciences Center, Inc. (Tampa General Hospital), a billion dollar revenue, not-for-profit hospital.

Jeff Thompson, Board Member

read more

Mr. Thompson is the Operating Partner for HealthEdge Investment Partners’ portfolio companies in their Healthcare Products Group. HealthEdge is an operating-oriented private equity firm founded in 2005 that provides strategic capital exclusively in the healthcare industry. Mr. Thompson is responsible for managing the portfolio companies of the Healthcare Products Group and currently serves as President, CEO and Chairman of Advanced Bio-Technologies, Inc. and as Chairman of Woodbury Products, Inc., both HealthEdge Healthcare Products Group portfolio companies. He also serves as a member of of the Board of Directors for Anika Therapeutics, Inc., a publicly traded Bedford, Massachusetts based biotechnology company that develops, manufactures and commercializes therapeutic hylauronic acid based products for tissue protection, healing, repair and regeneration. Prior to joining HealthEdge, Mr. Thompson was Chief Operating Officer for Stiefel Laboratories, Inc., the world’s largest independent pharmaceutical company specializing in dermatology with revenues of approximately $1 billion. He served as a member of Stiefel’s Board of Directors through Glaxo SmithKline’s $3.6 billion acquisition of Stiefel. Prior to becoming Stiefel’s COO, Mr. Thompson served as Stiefel’s Senior Vice President U.S. Business Services and President of Glades Pharmaceuticals. During his tenure in this dual leadership role, Glades grew from $36 million to over $73 million. Earlier in his career, Mr. Thompson held Sales and Business Management positions at Bausch & Lomb Pharmaceuticals and he began his career at SmithKline Beecham as a Professional Sales Representative. Mr. Thompson received his Bachelor’s degree in General Science and completed one year of study in Dental Medicine, both at the University of Pittsburgh.